It has been shown that EzH2 down-regulation can reduce growth of invasive breast carcinoma [15–17], tumor angiogenesis [20], cell migration/invasion and metastasis in colorectal cancer cells [13, 21]. The gene discussed is EZH2; the disease is invasive breast carcinoma.